Zhang, Xiaoqian Wen, Long Chen, Shanwen Zhang, Junling Ma, Yongchen Hu, Jianwen Yue, Taohua Wang, Jingui Zhu, Jing Bu, Dingfang Wang, Xin Additional file 1 of The novel long noncoding RNA CRART16 confers cetuximab resistance in colorectal cancer cells by enhancing ERBB3 expression via miR-371a-5p Additional file 1: Figure S1. Phenotypic characteristics of Caco-2 and Caco-2 CR cells. a Flow cytometry was performed in Caco-2 and Caco-2 CR cells with cetuximab treatment (100 μg/ml and 200 μg/ml) for 48 h. APC Annexin V−/7-AAD− denotes live cells; APC Annexin V+/7-AAD− denotes early apoptotic cells; APC Annexin V−/7-AAD+ denotes necrotic cells; and APC Annexin V+/7-AAD+ denotes late apoptotic cells. b The cell cycle was assessed by flow cytometry in Caco-2 and Caco-2 CR cells after 48 h of treatment with cetuximab (200 μg/ml). c The percentage of EGFR-, ERBB3-, and c-MET-positive cells and the MFI were determined by GALLIOUS flow cytometry in Caco-2 and Caco-2 CR cells. d Flow cytometry analysis showed the expression of stemness biomarkers of CRC cells, CD44 and CD133, in Caco-2 and Caco-2 CR cells. Long noncoding RNA;CRART 16;Cetuximab;Resistance;miR-371a-5p;ERBB3 2020-03-05
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_The_novel_long_noncoding_RNA_CRART16_confers_cetuximab_resistance_in_colorectal_cancer_cells_by_enhancing_ERBB3_expression_via_miR-371a-5p/11937768
10.6084/m9.figshare.11937768.v1